Literature DB >> 12826737

Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia.

Cezary Zekanowski1, Beata Pepłońska, Maria Styczyńska, Katarzyna Gustaw, Jacek Kuźnicki, Maria Barcikowska.   

Abstract

Frontotemporal dementia (FTD) is a common neurodegenerative disorder and is connected with about 10% of all dementias. In approximately half of all FTD cases, a positive family history has been reported. To date, several mutations at the tau protein gene (MAPT) were identified causing familial and sporadic FTD. Extensive polymorphic variability at the MAPT gene has also been shown to be a risk factor in progressive supranuclear palsy (PSP). The recently described gene Saitohin (STH), located in the intron 9 of MAPT gene, was also reported to be polymorphic. In the present study 23 unrelated Polish patients with clinically defined sporadic and familial FTD were screened for mutations at the MAPT gene. No pathogenic mutations were found in the group. Several novel silent intronic and exonic mutations were identified, most of them associated with two common haplotypes. In the reported group no correlation between extended MAPT haplotype and APOE genotype was determined. There was also no observed relation between age of onset and APOE status. At the STH gene only a common polymorphic change was found. It is postulated that MAPT mutations are not connected with most of the FTD cases in the Polish population. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826737     DOI: 10.1159/000070999

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

1.  Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings.

Authors:  Cristina Lorenzi; Alessandra Marcone; Adele Pirovano; Elena Marino; Francesco Cordici; Chiara Cerami; Dario Delmonte; Stefano F Cappa; Placido Bramanti; Enrico Smeraldi
Journal:  Neurol Sci       Date:  2010-09-18       Impact factor: 3.307

2.  Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).

Authors:  Tomasz Gabryelewicz; Mario Masellis; Mariusz Berdynski; Juan M Bilbao; Ekaterina Rogaeva; Peter St George-Hyslop; Anna Barczak; Krzysztof Czyzewski; Maria Barcikowska; Zbigniew Wszolek; Sandra E Black; Cezary Zekanowski
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Variation at APOE and STH loci and Alzheimer's disease.

Authors:  Lingjun Zuo; Christopher H van Dyck; Xingguang Luo; Henry R Kranzler; Bao-zhu Yang; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2006-04-07       Impact factor: 3.759

4.  Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.

Authors:  Gamze Guven; Ebba Lohmann; Jose Bras; J Raphael Gibbs; Hakan Gurvit; Basar Bilgic; Hasmet Hanagasi; Patrizia Rizzu; Peter Heutink; Murat Emre; Nihan Erginel-Unaltuna; Walter Just; John Hardy; Andrew Singleton; Rita Guerreiro
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

5.  Two Rare Variants in PLAU and BACE1 Genes-Do They Contribute to Semantic Dementia Clinical Phenotype?

Authors:  Katarzyna Gaweda-Walerych; Emilia J Sitek; Małgorzata Borczyk; Mariusz Berdyński; Ewa Narożańska; Bogna Brockhuis; Michał Korostyński; Jarosław Sławek; Cezary Zekanowski
Journal:  Genes (Basel)       Date:  2021-11-17       Impact factor: 4.096

6.  Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.

Authors:  Anna-Lotta Kaivorinne; Johanna Krüger; Katja Kuivaniemi; Hannu Tuominen; Virpi Moilanen; Kari Majamaa; Anne M Remes
Journal:  BMC Neurol       Date:  2008-12-17       Impact factor: 2.474

7.  A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.

Authors:  Abhinaya Iyer; Nichole E Lapointe; Krzysztof Zielke; Mariusz Berdynski; Elmer Guzman; Anna Barczak; Małgorzata Chodakowska-Żebrowska; Maria Barcikowska; Stuart Feinstein; Cezary Zekanowski
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.